Russell McMahen

Chief Tech/Sci/R&D Officer at AYTU BIOPHARMA, INC.

Health Technology

Consumer Services

Profile

Russell Lee McMahen is currently the Senior Vice President-Research & Development at Aytu Biopharma, Inc. He previously worked as the Senior Vice President-Research & Development at Neos Therapeutics, Inc. from 2011 to 2021.
Prior to that, he was a Principal at IVAX Pharmaceuticals, Inc. He obtained his undergraduate degree from Louisiana Tech University.

Russell McMahen active positions

Companies	Position	Start
AYTU BIOPHARMA, INC.	Chief Tech/Sci/R&D Officer	31/12/2020

All active positions of Russell McMahen

Former positions of Russell McMahen

Companies	Position	End
NEOS THERAPEUTICS, INC.	Chief Operating Officer	-
IVAX Pharmaceuticals, Inc. IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IVAX Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products, which are sold to wholesalers, retail drug chains, retail pharmacies, hospital groups, nursing home providers and government agencies in the United States. The company was founded in 1987 by Philip Frost and Michael Jaris. It is headquartered in Miami, FL.	Corporate Officer/Principal	-

See the detail of Russell McMahen's experience

Training of Russell McMahen

Louisiana Tech University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Russell McMahen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
AYTU BIOPHARMA, INC.	Health Technology

Private companies	2
Neos Therapeutics, Inc. Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX.	Health Technology
IVAX Pharmaceuticals, Inc. IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IVAX Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products, which are sold to wholesalers, retail drug chains, retail pharmacies, hospital groups, nursing home providers and government agencies in the United States. The company was founded in 1987 by Philip Frost and Michael Jaris. It is headquartered in Miami, FL.	Health Technology